Actively Recruiting
Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
Led by Otsuka Pharmaceutical Co., Ltd. · Updated on 2025-03-21
1000
Participants Needed
1
Research Sites
374 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the long-term safety of AJOVY in patients under actual use conditions and to specifically evaluate cardiovascular events. In addition, information on efficacy will be collected.
CONDITIONS
Official Title
Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
Who Can Participate
Eligibility Criteria
You may qualify if you...
Age between 18 and 65 years Diagnosed with the specified medical condition Willing to follow all study procedures and visit schedules Able to provide informed consent and comply with study requirements
You will not qualify if you...
- Patients with a known hypersensitivity to components of AJOVY
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pharmacovigilance Department
Osaka, Japan, 540-0021
Actively Recruiting
Research Team
P
Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here